Originally published on Technavio:Molecular Diagnostics Market Research Report on Products, Applications, and Geography - Forecast and Analysis 2023-2027
The projected Molecular Diagnostics Market size is set to expand by USD 7,722.71 million, demonstrating a Compound Annual Growth Rate (CAGR) of 5.96% from 2022 to 2027. The market's growth hinges on various factors, including the increased prevalence of age-related diseases, the global adoption of advanced treatment solutions, and the heightened demand from developing countries.
Market Definition
Molecular diagnostics, a subset of laboratory medicine, involves the detection and analysis of genetic material, such as DNA and RNA, to diagnose diseases, predict disease progression, select appropriate therapies, and monitor treatment response. This field utilizes techniques and technologies to identify and characterize specific genetic sequences or alterations associated with various diseases or conditions. Encompassing a wide range of tests and methodologies, molecular diagnostics aids healthcare professionals in gaining insights into individuals' genetic information.
Market Dynamics
Researchers conducted a thorough analysis of data using 2022 as the base year, focusing on key drivers, trends, and challenges. A holistic examination of drivers is crucial for companies to refine their marketing strategies and gain a competitive advantage.
Key Market Driver
The heightened prevalence of age-related diseases serves as the primary driver for market growth. The increasing geriatric population significantly impacts the demand, with age-related diseases, such as cardiovascular diseases, cancer, neurodegenerative disorders, and chronic conditions like diabetes, being more susceptible in older individuals.
Molecular diagnostics play a critical role in the early detection, diagnosis, and monitoring of these diseases by providing personalized information about an individual's genetic predisposition, disease symptoms and progression, and response to control measures and treatment.
Prominent Market Trends
The integration of next-generation sequencing (NGS) stands out as the primary trend driving global market growth. NGS technologies have revolutionized molecular diagnostics, enabling high-level analysis of genetic information. NGS allows for significant analysis of multiple genes or entire genomes, providing comprehensive genetic profiling for disease diagnosis, symptoms, and treatment selection. NGS has become a necessary tool in genomics research and drug development.
Primary Market Challenge
Inadequate medical reimbursements pose a major challenge to global market growth. Given the expense of modern diagnostic products, proper medical reimbursement is crucial. Limited reimbursements impact the utilization of these modern devices. For instance, in the US, the Centers for Medicare and Medicaid Services provide reimbursements for only a few diagnostic test kit products.
Major Market Companies
Companies are employing various strategies, including strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories: The company offers molecular diagnostics tests that support COVID-19 testing with automated, high-throughput systems catering to different laboratory needs.
The research report includes detailed analyses of the competitive landscape of the market and information about 20 market companies.
Market Segmentation
The global market share growth by the instruments segment is expected to be significant during the forecast period. In the past five years, molecular diagnostic instruments have witnessed notable advancements. These advancements include the development of faster and more accurate nucleic acid amplification techniques like polymerase chain reaction (PCR) and isothermal amplification methods. Additionally, the emergence of next-generation sequencing (NGS) platforms has revolutionized genomic analysis.
Molecular Diagnostics Market Size
The instruments segment exhibited gradual market share growth, reaching USD 14,426.77 million in 2017 and continuing to grow by 2021. The continuous improvement and accessibility of these technologies are meeting the rising demand for molecular diagnostic instruments. These instruments play an essential role in research and development efforts across various fields, including genomics, pharmaceuticals, and biotechnology. The demand for molecular diagnostic instruments is driven by ongoing research and development activities, positively impacting the growth of the global market during the forecast period.
Key Regions
Molecular Diagnostics Market Share by Geography
For insights into the market share of various regions, download a PDF sample now.
Asia is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Countries such as China, India, and Japan have experienced outbreaks of infectious diseases, including COVID-19, dengue, tuberculosis, and hepatitis. The rising demand for molecular diagnostic tests to detect and monitor these disease .
To Learn deeper into this report , View Sample PDF
The Molecular Diagnostics Market is transforming healthcare with advancements in artificial intelligence, digital polymerase chain reaction, and RNA-Seq technologies, enabling precise cellular differentiation and cancer treatment.
For more information please contact.
Technavio Research
Jesse Maida
Media Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
